What is the current stock price of IDEXX Laboratories, Inc. (IDXX)?

As of the latest market data, IDEXX Laboratories, Inc. (IDXX) is trading at $563.00. The stock has seen a loss of -3.72% today.

Does IDEXX Laboratories, Inc. (IDXX) pay a dividend?

Based on current data, IDEXX Laboratories, Inc. does not have a confirmed active dividend policy.

What is the market cap of IDEXX Laboratories, Inc.?

The current market capitalization of IDEXX Laboratories, Inc. (IDXX) is approximately unavailable.

IDXX

IDEXX Laboratories, Inc.·Healthcare

563.00

3.720%(−21.75)

Market Closed

600.84

6.721%(+37.84)

After Hours

Last Updated: — ET

52W L: $391.0552W H: $769.98

IDXX NEWS

businesswire.com

2d ago

IDEXX Laboratories to Release 2026 First Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q1 2026 Earnings Snapshot through a link on the IDEXX website,.

zacks.com

4d ago

Idexx (IDXX) Upgraded to Buy: Here's Why

Idexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com

Apr 3

Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

businesswire.com

Apr 1

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Cancer Dx Panel with canine lymphoma detection helps clinicians investigate sooner and plan next steps with confidence.

defenseworld.net

Mar 30

IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 11.9% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 62,951 shares of the company's stock after buying an additional 6,710 shares during the period. IDEXX Laboratories accounts for

defenseworld.net

Mar 24

IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co.

Congress Asset Management Co. increased its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 9,894.0% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 153,908 shares of the company's stock after purchasing an additional 152,368 shares during the quarter. Congress

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

11,000

IPO Date

1991-06-21

Beta

1.72

Websitewww.idexx.com↗